A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital

Pneumocystis jirovecii pneumonia (PJP) is a life-threatening and severe disease in immunocompromised hosts. A synergistic regimen based on the combination of sulfamethoxazole-trimethoprim (SMX-TMP) with caspof...

Source: BMC Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Hao Li, Yihe Lu, Guoxin Tian, Yongxing Wu, Tianjun Chen, Jiangwei Zhang, Nan Hu, Xiaoning Wang, Yang Wang, Lan Gao, Jinqi Yan, Linjing Zhou and Qindong Shi Tags: Research Source Type: research